1. Home
  2. EPIX vs GCV Comparison

EPIX vs GCV Comparison

Compare EPIX & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • GCV
  • Stock Information
  • Founded
  • EPIX 2009
  • GCV 1988
  • Country
  • EPIX Canada
  • GCV United States
  • Employees
  • EPIX N/A
  • GCV N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • GCV Finance/Investors Services
  • Sector
  • EPIX Health Care
  • GCV Finance
  • Exchange
  • EPIX Nasdaq
  • GCV Nasdaq
  • Market Cap
  • EPIX 65.3M
  • GCV 75.6M
  • IPO Year
  • EPIX N/A
  • GCV N/A
  • Fundamental
  • Price
  • EPIX $1.72
  • GCV $3.59
  • Analyst Decision
  • EPIX Hold
  • GCV
  • Analyst Count
  • EPIX 3
  • GCV 0
  • Target Price
  • EPIX $2.00
  • GCV N/A
  • AVG Volume (30 Days)
  • EPIX 280.5K
  • GCV 57.9K
  • Earning Date
  • EPIX 05-08-2025
  • GCV 01-01-0001
  • Dividend Yield
  • EPIX N/A
  • GCV 13.04%
  • EPS Growth
  • EPIX N/A
  • GCV N/A
  • EPS
  • EPIX N/A
  • GCV N/A
  • Revenue
  • EPIX N/A
  • GCV N/A
  • Revenue This Year
  • EPIX N/A
  • GCV N/A
  • Revenue Next Year
  • EPIX N/A
  • GCV N/A
  • P/E Ratio
  • EPIX N/A
  • GCV N/A
  • Revenue Growth
  • EPIX N/A
  • GCV N/A
  • 52 Week Low
  • EPIX $1.40
  • GCV $3.15
  • 52 Week High
  • EPIX $7.88
  • GCV $4.58
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 52.43
  • GCV 54.26
  • Support Level
  • EPIX $1.67
  • GCV $3.53
  • Resistance Level
  • EPIX $1.79
  • GCV $3.59
  • Average True Range (ATR)
  • EPIX 0.08
  • GCV 0.07
  • MACD
  • EPIX -0.01
  • GCV 0.02
  • Stochastic Oscillator
  • EPIX 21.28
  • GCV 87.50

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.

Share on Social Networks: